Tumor necrosis factor-alpha (TNFα) antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and ankylosing spondylitis [1, 2]. This evidence concerns the gene TNF and vasculitis.